Search research articles
Contact Us
Filters
Showing results (161-170 of 275) with videos related to
Page
of 28
Sort By:
Bone Marrow Transplantation
|
August 8, 2023
Placental expanded mesenchymal-like cells (PLX-R18) for poor graft function after hematopoietic cell transplantation: A phase I study
Joseph P McGuirk, Leland Metheny, Luis Pineiro, et al.
Leukemia Research
|
January 24, 2019
The relationship between clinical trial accrual volume and outcomes in acute myeloid leukemia: A SWOG/ECOG-ACRIN study (S0106 and E1900)
Bruno C Medeiros, Megan Othus, Martin S Tallman, et al.
Leukemia & Lymphoma
|
April 4, 2019
Superior outcome of patients with favorable-risk acute myeloid leukemia using consolidation with autologous stem cell transplantation
Ofrat Beyar-Katz, Noa Lavi, Shimrit Ringelstein-Harlev, et al.
Molecular Cancer Therapeutics
|
April 17, 2012
Preclinical analysis of the γ-secretase inhibitor PF-03084014 in combination with glucocorticoids in T-cell acute lymphoblastic leukemia
Jeremy B Samon, Mireia Castillo-Martin, Michael Hadler, et al.
Blood
|
September 27, 2003
A phase 3 study of three induction regimens and of priming with GM-CSF in older adults with acute myeloid leukemia: a trial by the Eastern Cooperative Oncology Group
Jacob M Rowe, Donna Neuberg, William Friedenberg, et al.
Leukemia & Lymphoma
|
December 29, 2004
Phase II study of all-trans retinoic acid in the accelerated phase or early blastic phase of chronic myeloid leukemia: a study of the Eastern Cooperative Oncology Group (E1993)
Janice P Dutcher, Sandra Lee, Robert E Gallagher, et al.
Blood
|
July 1, 2009
Treatment of myelodysplastic syndrome patients with erythropoietin with or without granulocyte colony-stimulating factor: results of a prospective randomized phase 3 trial by the Eastern Cooperative Oncology Group (E1996)
Peter L Greenberg, Zhuoxin Sun, Kenneth B Miller, et al.
British Journal of Haematology
|
October 7, 2009
Failure of three novel regimens to improve outcome for patients with relapsed or refractory acute myeloid leukaemia: a report from the Eastern Cooperative Oncology Group
Mark R Litzow, Megan Othus, Larry D Cripe, et al.
Leukemia & Lymphoma
|
December 29, 2004
Intensified induction chemotherapy in adult acute myeloid leukemia followed by high-dose chemotherapy and autologous peripheral blood stem cell transplantation: an Eastern Cooperative Oncology Group trial (E4995)
Peter A Cassileth, Sandra J Lee, Mark R Litzow, et al.
Nature Reviews. Clinical Oncology
|
September 6, 2012
The European LeukemiaNet AML Working Party consensus statement on allogeneic HSCT for patients with AML in remission: an integrated-risk adapted approach
Jan J Cornelissen, Alois Gratwohl, Richard F Schlenk, et al.
Page
of 28
Search research articles
Search
Showing results (161-170 of 275) with videos related to
Sort By:
Page
of 28
Bone Marrow Transplantation
|
August 8, 2023
Placental expanded mesenchymal-like cells (PLX-R18) for poor graft function after hematopoietic cell transplantation: A phase I study
Joseph P McGuirk, Leland Metheny, Luis Pineiro, et al.
Leukemia Research
|
January 24, 2019
The relationship between clinical trial accrual volume and outcomes in acute myeloid leukemia: A SWOG/ECOG-ACRIN study (S0106 and E1900)
Bruno C Medeiros, Megan Othus, Martin S Tallman, et al.
Leukemia & Lymphoma
|
April 4, 2019
Superior outcome of patients with favorable-risk acute myeloid leukemia using consolidation with autologous stem cell transplantation
Ofrat Beyar-Katz, Noa Lavi, Shimrit Ringelstein-Harlev, et al.
Molecular Cancer Therapeutics
|
April 17, 2012
Preclinical analysis of the γ-secretase inhibitor PF-03084014 in combination with glucocorticoids in T-cell acute lymphoblastic leukemia
Jeremy B Samon, Mireia Castillo-Martin, Michael Hadler, et al.
Blood
|
September 27, 2003
A phase 3 study of three induction regimens and of priming with GM-CSF in older adults with acute myeloid leukemia: a trial by the Eastern Cooperative Oncology Group
Jacob M Rowe, Donna Neuberg, William Friedenberg, et al.
Leukemia & Lymphoma
|
December 29, 2004
Phase II study of all-trans retinoic acid in the accelerated phase or early blastic phase of chronic myeloid leukemia: a study of the Eastern Cooperative Oncology Group (E1993)
Janice P Dutcher, Sandra Lee, Robert E Gallagher, et al.
Blood
|
July 1, 2009
Treatment of myelodysplastic syndrome patients with erythropoietin with or without granulocyte colony-stimulating factor: results of a prospective randomized phase 3 trial by the Eastern Cooperative Oncology Group (E1996)
Peter L Greenberg, Zhuoxin Sun, Kenneth B Miller, et al.
British Journal of Haematology
|
October 7, 2009
Failure of three novel regimens to improve outcome for patients with relapsed or refractory acute myeloid leukaemia: a report from the Eastern Cooperative Oncology Group
Mark R Litzow, Megan Othus, Larry D Cripe, et al.
Leukemia & Lymphoma
|
December 29, 2004
Intensified induction chemotherapy in adult acute myeloid leukemia followed by high-dose chemotherapy and autologous peripheral blood stem cell transplantation: an Eastern Cooperative Oncology Group trial (E4995)
Peter A Cassileth, Sandra J Lee, Mark R Litzow, et al.
Nature Reviews. Clinical Oncology
|
September 6, 2012
The European LeukemiaNet AML Working Party consensus statement on allogeneic HSCT for patients with AML in remission: an integrated-risk adapted approach
Jan J Cornelissen, Alois Gratwohl, Richard F Schlenk, et al.
Page
of 28